Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T14:42:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A 403 Forbidden page now replaces the study record for the NCT04740918 entry, displaying a 403 message and basic navigation. The detailed study content and documents are no longer accessible through the page.
    Difference
    19%
    Check dated 2026-09-19T19:22:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor update in the page's versioning metadata without changes to study details.
    Difference
    0.0%
    Check dated 2026-09-05T20:34:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study record now includes links to the Study Protocol and Statistical Analysis Plan, adds an IPD sharing plan, and notes that the trial operates at 51 locations.
    Difference
    81%
    Check dated 2026-08-15T23:17:23.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects an updated revision stamp for the page.
    Difference
    0.0%
    Check dated 2026-08-08T17:48:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page. This represents an administrative update to the study record rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-07-25T08:22:34.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.